Skip to content

Study on the correlation and mechanism of MBOAT7 rs641738 single nucleotide polymorphism with non-obese fatty liver

Study on the correlation and mechanism of MBOAT7 rs641738 single nucleotide polymorphism with non-obese fatty liver

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077023
Enrollment
Unknown
Registered
2023-10-26
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease,NAFLD

Interventions

patients with non-obese fatty liver disease:NA
patients with obese fatty liver disease:NA

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) pathological liver adipose area =5% (2) aged between 18 and 80 years (3) agree to sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Lack of necessary demographic indicators, body measurement indicators, laboratory indicators, etc (2) Lack of necessary prior history and medication history (3) Liver disease with other causes, such as HBV, HCV infection, autoimmune liver disease and other diseases; A history of heavy alcohol consumption (alcohol intake > 210g/ day for men and > 140g/ day for women); Secondary hepatic steatosis caused by drugs, such as tamoxifen, hormones, etc (4) Combined with other serious diseases that may affect the nutritional status of the body, such as malignant tumors, serious organic diseases of the heart, lungs, kidneys, etc

Design outcomes

Primary

MeasureTime frame
MBOAT7 rs641738 gene polymorphism;liver adipose area;

Secondary

MeasureTime frame
pathological score and non-invasive liver fibrosis score;liver function, blood routine, blood lipid, blood glucose;anthropometric indicators;liver and plasma lipidomics;

Countries

China

Contacts

Public ContactHaiqing Guo

Beijing Youan Hospital, Capital Medical University

guotianlove@126.com+86 185 1086 4557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026